As digital health technologies accumulate more and more patient data, stakeholders across the healthcare value chain are looking to digital biomarkers as crucial counterparts to clinical biomarker data

Transformation Roadmap for Pharmacovigilance in Digital Era

Life sciences companies are trying to keep pace with the customer. They are moving from treatment to preventive scenarios. But are they doing enough?

An unprecedented rise of the failing M&A's has resulted in enormous financial and operational losses. Data Lakes has successfully addressed the problem by offering flexible data options for real time reporting,application integration and simplifying information systems.

Today's patients see digital technology as an enabler in their journey to wellness - they are always connected, and this has fundamentally changed their expectations and behaviors. Read on to know more how the technology landscape is enabling this revolution in healthcare.

Digitization of processes and data across the value chain along with the emergence of Internet of Things (IoT) has transformed the Pharma industry. Although IoT is still in its nascent stages of adoption in the Life Sciences industry, the use of smart devices and machine-to-machine (M2M) communication leveraging SMAC technologies comes at a time when the industry is grappling with patent cliffs and declining R&D productivity

Written by: Alan Louie, Research Director, Life Sciences, IDC Health Insights, and Michael Townsend, Research Director, Life Sciences Commercial Strategies, IDC Health Insights

A ready reckoner on how blockchain is eliminating occurrences of degraded temperature sensitive drugs due to broken cold chain logistics

A ready reckoner on how blockchain is eliminating occurrences of degraded temperature sensitive drugs due to broken cold chain logistics

Read about the opportunities and challenges when the vastly underserved healthcare market, combined with high mobile phone penetration and rapidly growing smartphone adoption creates ideal conditions for mHealth adoption.

Big data enabled consolidation and collaboration among different internal and external healthcare stakeholders will benefit pharma companies by breaking the silos that separate internal functions and enhance integrated, consistent research and care management.

What are your views on the social strategies that life sciences companies should adopt? Have you come across an interesting example of social engagement from a life sciences company?

Understand the significance of manufacturing analytics in Pharma with the changing times and cost pressure

Understand how the reforms under the accountability care act will shape the healthcare landscape, and more importantly, how it will impact the patients.

Roughly 10% of the case-patient participants identified as Black.

Speed in taking much needed vaccines and drugs to market was never as important as now. With the novel Coronavirus (COVID-19) pandemic threatening casualties en-masse, speed of clinical research is a matter of life and death.

Data driven insights to accelerate clinical study start up and planning

This edition talks about how analytics done right can help organizations foster innovation, secure the present and accelerate growth.

Risk Stratification in Patient Centric Models

Watch Shalini Sharad, Practice Leader – Commercial Innovation, Healthcare and Life sciences, Wipro, talk about this transition and how innovation in healthcare technology will be key to enabling an integrated delivery network centered around the patient.

Emerging pharmaceutical technologies can aid in rapid drug and vaccine development — but only if pharma companies prioritize digitization initiatives.